Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database

Rachel H Mulholland, Eleftheria Vasileiou* (Corresponding Author), Colin R Simpson, Chris Robertson, Lewis D Ritchie, Utkarsh Agrawal, Mark Woolhouse, Josephine Lk Murray, Helen R Stagg, Annemarie B Docherty, Colin McCowan, Rachael Wood, Sarah J Stock, Aziz Sheikh

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)


In December 2019, a novel coronavirus COVID-19 emerged from Wuhan, China, and was soon declared as pandemic by the World Health Organization (WHO) on the 11 March 2020.1 The UK soon followed suit and implemented a national lockdown on the 23 March 2020. As of 9 December 2020, according to WHO, this highly infectious virus has infected more than 67 million people and led to over 1.5 million deaths across the world.2 There is a growing body of evidence on the epidemiology of the condition, risk factors for poor outcomes and effects of interventions.3–9

Original languageEnglish
Pages (from-to)1064-1074
Number of pages11
JournalInternational Journal of Epidemiology
Issue number4
Early online date5 Jun 2021
Publication statusPublished - Aug 2021

Bibliographical note

The original EAVE project was funded by the National Institute for Health Research Health Technology Assessment Programme (project number 13/34/14). EAVE II is funded by the Medical Research Council [MR/R008345/1] and supported by the Scottish Government. This work is supported by BREATHE—The Health Data Research Hub for Respiratory Health [MC_PC_19004]. BREATHE is funded through 10 the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK.


  • Scotland
  • surveillance
  • medical
  • pandemics
  • covid-19


Dive into the research topics of 'Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database'. Together they form a unique fingerprint.

Cite this